Three cases in which drug-induced hyponatremia was improved by replacing carbamazepine with lacosamide.

antiepileptic drug carbamazepine hyponatremia lacosamide side effects

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 02 08 2019
revised: 08 03 2020
accepted: 19 03 2020
entrez: 23 7 2020
pubmed: 23 7 2020
medline: 23 7 2020
Statut: epublish

Résumé

Carbamazepine often causes drug-induced hyponatremia. Hyponatremia due to carbamazepine may be improved by changing to the same mechanism of action, lacosamide.

Identifiants

pubmed: 32695350
doi: 10.1002/ccr3.2857
pii: CCR32857
pmc: PMC7364071
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1166-1170

Informations de copyright

© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

None decalred.

Références

Epilepsia. 1994 Jan-Feb;35(1):181-8
pubmed: 8112243
Epilepsia. 1987;28 Suppl 3:S64-70
pubmed: 2961558
Kidney Int. 2007 Apr;71(8):822-6
pubmed: 17311074
Epilepsia. 2003 Mar;44(3):457-60
pubmed: 12614404
Epilepsy Behav. 2016 Sep;62:1-5
pubmed: 27423106
Epilepsy Behav. 2017 Apr;69:186-222
pubmed: 28237319
Epilepsia. 2006 Jul;47(7):1094-120
pubmed: 16886973
Ann Pharmacother. 2005 Nov;39(11):1943-6
pubmed: 16189283
Seizure. 2008 Jun;17(4):389-90
pubmed: 18584781
Expert Opin Drug Saf. 2017 Jan;16(1):77-87
pubmed: 27737595
Epilepsia. 2005 Jun;46(6):972-3
pubmed: 15946344
CNS Drugs. 2017 Jul;31(7):527-534
pubmed: 28523600
Clin J Am Soc Nephrol. 2011 May;6(5):960-5
pubmed: 21441132
Lancet Neurol. 2017 Jan;16(1):43-54
pubmed: 27889312
Epilepsia. 2017 Jul;58(7):1227-1233
pubmed: 28542738
Nephrol Dial Transplant. 2014 Apr;29 Suppl 2:i1-i39
pubmed: 24569496
Clin Endocrinol (Oxf). 2016 Aug;85(2):306-12
pubmed: 26715131

Auteurs

Masahito Morimoto (M)

Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities Tokushima Japan.

Ichiro Suzaki (I)

Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities Tokushima Japan.

Seishi Shimakawa (S)

Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities Tokushima Japan.

Toshiaki Hashimoto (T)

Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities Tokushima Japan.

Tadanori Nakatsu (T)

Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities Tokushima Japan.

Shigeaki Hamada (S)

Japanese Red Cross Tokushima Hinomine Rehabilitation Center for People with Disabilities Tokushima Japan.

Shojiro Kyotani (S)

Graduate School of Pharmaceutical Sciences Tokushima Bunri University Japan.

Classifications MeSH